Age-related anatomical changes are most effectively managed through the combination of science and technology. To achieve this goal, Neauvia’s research designed SMART COMBINATION THERAPY, which combines different restorative therapies and grants clinically proven superior results. 1, 2, 3
Created in 2012, Neauvia is distributed in more than 80 countries worldwide. Today, it stands as a high-growth multinational corporation with production sites and subsidiaries in Italy, Switzerland, France, Spain, Poland, Germany, the UK and the US.
Neauvia offers clinically proven combined solutions for healthcare practitioners and patients.
Part of the MatexLab Group, which is backed by leading central European private equity firm Abris Capital, Neauvia is a pioneer in medical aesthetics and has developed ground-breaking synergistic smart combination therapies.
Neauvia chose PEG differentiating itself in the market. PEG is a well-known polymer in the pharmaceutical market, due to its uniqueness, versatility and safety profile 4, 5.
Neauvia PEG-HA Fillers are based on a unique patented Smart Crosslinking Technology (SXT) which is an innovative and advanced technology that combines Hyaluronic Acid and PEGDE in one network.
NEAUVIA SCIENTIFIC ACADEMY has been created to provide highest quality medical education by supporting healthcare professionals in the development of their practice and skills for better patients’ outcomes. One of the main objectives of the NEAUVIA SCIENTIFIC ACADEMY is to strengthen medical knowledge from product research to the effective use in daily practice.